Trademark: 90483777
Word
G1 THERAPEUTICS
Status
Registered
Status Code
700
Status Date
Tuesday, September 13, 2022
Serial Number
90483777
Registration Number
6847725
Registration Date
Tuesday, September 13, 2022
Mark Type
4000
Filing Date
Friday, January 22, 2021
Published for Opposition
Tuesday, March 8, 2022

Trademark Owner History
G1 Therapeutics, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations for myeloprotection and anti-tumor effects; pharmaceutical preparations for reducing side effects of chemotherapy; pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatment of cancer; therapeutic preparations for use in patients with cancer
42 Pharmaceutical research and development; providing medical and scientific research information in the fields of oncology, pharmaceuticals, therapies, diseases, and disorders
G ONE THERAPEUTICS
"THERAPEUTICS"

Trademark Events
Sep 13, 2022
Notice Of Registration Confirmation Emailed
Sep 13, 2022
Registered-Principal Register
Aug 6, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 5, 2022
Allowed Principal Register - Sou Accepted
Jul 27, 2022
Statement Of Use Processing Complete
Jul 8, 2022
Use Amendment Filed
Jul 26, 2022
Case Assigned To Intent To Use Paralegal
Jul 8, 2022
Teas Statement Of Use Received
May 3, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 8, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 8, 2022
Published For Opposition
Feb 16, 2022
Notification Of Notice Of Publication E-Mailed
Jan 27, 2022
Assigned To Lie
Jan 26, 2022
Approved For Pub - Principal Register
Jan 20, 2022
Teas/Email Correspondence Entered
Jan 19, 2022
Correspondence Received In Law Office
Jan 19, 2022
Teas Response To Office Action Received
Jul 28, 2021
Notification Of Non-Final Action E-Mailed
Jul 28, 2021
Non-Final Action E-Mailed
Jul 28, 2021
Non-Final Action Written
Jul 17, 2021
Assigned To Examiner
Apr 24, 2021
New Application Office Supplied Data Entered
Jan 26, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24